» Articles » PMID: 28163424

Cardiac Magnetic Resonance Feature Tracking in Kawasaki Disease Convalescence

Overview
Date 2017 Feb 7
PMID 28163424
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study was to determine whether left ventricular (LV) myocardial deformation indices can detect subclinical abnormalities in Kawasaki disease convalescence. We hypothesized that subclinical myocardial abnormalities due to inflammation represent an early manifestation of the disease that persists in convalescence.

Background: Myocardial inflammation has been described as a global finding in the acute phase of Kawasaki disease. Despite normal systolic function by routine functional measurements, reduced longitudinal strain and strain rate have been detected by echocardiography in the acute phase.

Methods And Results: Peak systolic LV myocardial longitudinal, radial, and circumferential strain and strain rate were examined in 29 Kawasaki disease convalescent patients (15 males; mean [standard deviation] age: 11 [6.6] years; median interval from disease onset: 5.8 [5.4] years) and 10 healthy volunteers (5 males; mean age: 14 [3.8] years) with the use of cardiac magnetic resonance (CMR) feature tracking. Routine indices of LV systolic function were normal in both groups. Comparisons were made between normal controls and (i) the entire Kawasaki disease group, (ii) Kawasaki disease subgroup divided by coronary artery involvement. Average longitudinal and circumferential strain at all levels was lower in patients compared to normal controls. In subgroup analysis, both Kawasaki disease patients with and without a history of coronary involvement had similar longitudinal and circumferential strain at all levels and lower when compared to controls. There were lower circumferential and longitudinal values in Kawasaki disease patients with persisting coronary artery lesions when compared to those with regressed ones.

Conclusion: In this CMR study in Kawasaki disease convalescent patients with preserved routine functional indices, we detected lower circumferential and longitudinal strain values compared to normal controls, irrespective of the coronary artery status.

Citing Articles

Kawasaki Disease: A Never-ending Story?.

Lianza A, Diniz M, Sawamura K, Menezes C, Silva I, Leal G Eur Cardiol. 2023; 18:e47.

PMID: 37546182 PMC: 10398426. DOI: 10.15420/ecr.2023.15.


Global Myocardial Strain in Multisystem Inflammatory Syndrome in Children, Kawasaki Disease, and Healthy Children: A Network Meta-Analysis.

Liu K, Yu J, Song G Front Pediatr. 2022; 10:848306.

PMID: 35832589 PMC: 9272823. DOI: 10.3389/fped.2022.848306.


Evaluation of comprehensive myocardial contractility in children with Kawasaki disease by cardiac magnetic resonance in a large single center.

Yao Q, Hu X, He L Quant Imaging Med Surg. 2022; 12(1):481-492.

PMID: 34993095 PMC: 8666756. DOI: 10.21037/qims-20-1402.


Biomarkers of inflammation and fibrosis in young adults with history of Kawasaki disease.

Hoshino S, Jain S, Shimizu C, Roberts S, He F, Daniels L Int J Cardiol Heart Vasc. 2021; 36:100863.

PMID: 34504945 PMC: 8413893. DOI: 10.1016/j.ijcha.2021.100863.


Cardiac magnetic resonance feature tracking of the right ventricle in convalescent Kawasaki disease in a large single center.

Yao Q, Hu X, He L Clin Cardiol. 2020; 44(1):108-115.

PMID: 33179816 PMC: 7803351. DOI: 10.1002/clc.23512.


References
1.
Kurotobi S, Kawakami N, Shimizu K, Aoki H, Nasuno S, Takahashi K . Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol. 2005; 26(4):425-30. DOI: 10.1007/s00246-004-0812-4. View

2.
Moran A, Newburger J, Sanders S, Parness I, Spevak P, Burns J . Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J. 2000; 139(2 Pt 1):217-23. DOI: 10.1067/mhj.2000.101221. View

3.
Yutani C, Go S, Kamiya T, Hirose O, Misawa H, Maeda H . Cardiac biopsy of Kawasaki disease. Arch Pathol Lab Med. 1981; 105(9):470-3. View

4.
Anderson T, Meyer R, Kaplan S . Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease. Am Heart J. 1985; 110(1 Pt 1):107-15. DOI: 10.1016/0002-8703(85)90523-x. View

5.
Rowley A, Shulman S . Recent advances in the understanding and management of kawasaki disease. Curr Infect Dis Rep. 2011; 12(2):96-102. PMC: 3043557. DOI: 10.1007/s11908-010-0091-6. View